Motilent Limited (08730130) is a private limited with share capital incorporated on 14/10/2013 (12 years old) and registered in london, E18FA. The company operates under SIC code 62020 and is classified as Small.
Motilent is a technology sme focused on delivering innovative services for the quantitative investigation of the gut. motilent champions the use of novel mri post-processing software as a cheaper and safer biomarker for gastrointestinal and bowel disorders, providing quantitative end points for rese...
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:25-07-2024
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:03-03-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:12-12-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:25-02-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:25-02-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:03-02-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:19-12-2022
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:28-11-2022
Change Person Director Company With Change Date
Category:Officers
Date:28-11-2022
Change Person Director Company With Change Date
Category:Officers
Date:28-11-2022
Memorandum Articles
Category:Incorporation
Date:13-04-2022
Resolution
Category:Resolution
Date:13-04-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:18-02-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:20-12-2021
Second Filing Of Confirmation Statement With Made Up Date
Category:Confirmation Statement
Date:11-11-2021
Confirmation Statement
Category:Confirmation Statement
Date:22-10-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:30-09-2021
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:31-03-2021
Confirmation Statement With Updates
Category:Confirmation Statement
Date:21-10-2020
Change Account Reference Date Company Previous Extended
Category:Accounts
Date:31-07-2020
Resolution
Category:Resolution
Date:11-06-2020
Capital Allotment Shares
Category:Capital
Date:29-04-2020
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:21-10-2019
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:30-07-2019
Confirmation Statement With Updates
Category:Confirmation Statement
Date:09-10-2018
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:30-07-2018
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:26-07-2018
Resolution
Category:Resolution
Date:11-01-2018
Capital Allotment Shares
Category:Capital
Date:08-01-2018
Capital Alter Shares Consolidation
Category:Capital
Date:08-01-2018
Resolution
Category:Resolution
Date:04-01-2018
Confirmation Statement With Updates
Category:Confirmation Statement
Date:17-10-2017
Accounts With Accounts Type Total Exemption Small
Category:Accounts
Date:31-07-2017
Confirmation Statement With Updates
Category:Confirmation Statement
Date:26-10-2016
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:28-07-2016
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:07-06-2016
Annual Return Company With Made Up Date Full List Shareholders
Category:Annual Return
Date:10-11-2015
Appoint Person Director Company With Name Date
Category:Officers
Date:10-11-2015
Change Person Director Company With Change Date
Category:Officers
Date:10-11-2015
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:09-07-2015
Annual Return Company With Made Up Date Full List Shareholders
Category:Annual Return
Date:29-10-2014
Incorporation Company
Category:Incorporation
Date:14-10-2013
Innovate Grants
4
This company received a grant of £989648.8 for Quantitative Reporting In Crohn’S Disease: Maximising Available Mri Data To Better Direct Patient Treatment, Speed Up Treatment Decisions And Improve Healthcare Outcomes. The project started on 01/04/2020 and ended on 31/03/2023.
This company received a grant of £182000.0 for Quantitative Reporting In Crohn’S Disease: Maximising Available Mri Data To Better Direct Patient Treatment, Speed Up Treatment Decisions And Improve Healthcare Outcomes. The project started on 01/06/2020 and ended on 30/11/2020.
